Search results
Results from the WOW.Com Content Network
Jefferies downgraded Biogen Inc (NASDAQ:BIIB), citing the company’s tough setup. Leqembi (lecanemab) sales growth remains sluggish, falling below consensus projections through 2030. Challenges ...
There were concerns that the cost of new plaque-targeting Alzheimer's drugs could overwhelm the program's finances, which provide care for 60 million seniors. Leqembi is priced at about $26,500 ...
(Reuters) -Biogen's Alzheimer's drug, Leqembi, will do well in the market whether a competitor comes or not, a company executive said at the Goldman Sachs Global Healthcare Conference on Wednesday.
Lecanemab, sold under the brand name Leqembi, is a monoclonal antibody medication used for the treatment of Alzheimer's disease. [ 2 ] [ 4 ] Lecanemab is an amyloid beta -directed antibody. [ 2 ] It is given via intravenous infusion to patients with mild cognitive impairment or mild dementia. [ 2 ]
That won't be enough to monitor patients who get on Leqembi, which reduces cognitive decline in mild to moderate Alzheimer's patients to avoid severe side effects, according to the company.
The following list includes projects to build new highways or improve existing ones, including roadways, bridges, and tunnels. It includes only projects that are underway or completed. Additionally, projects with multiple independent segments (e.g., I-69 Indiana-Texas Extension , Trans-Texas Corridor ) are not included, though individual ...
Leqembi's sales are projected to grow 13-fold to 56.5 billion yen ($361.28 million) in fiscal 2024 from the year ended in March, Eisai said in its annual results on Wednesday.
Steel shortages during World War I led the US to build experimental concrete ships, the largest of which was the SS Selma, today partially submerged in Galveston Bay and visible from both the Houston Ship Channel and Seawolf Park. SS Selma was built in Mobile, Alabama, and named to honor Selma, Alabama, for its successful wartime liberty loan ...